Trial
NCT02105116
AML Therapy With Irradiated Allogeneic Cells
UnknownTERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Rutgers, The State University of New Jersey
Collaborators
National Cancer Institute (NCI); Rutgers Cancer Institute of New Jersey
Condition
Adult Acute Megakaryoblastic Leukemia (M7)
Intervention
fludarabine phosphate
Why stopped
No patients were eligible to receive the experimental component of the protocol therapy.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-08-24